When scientists and clinicians submit papers they give away the fruits of their labour in order to advance scientific progress and to register their part in that advancement. Publishers undoubtedly add value to the research papers they receive by administering the process of peer review, editing and formatting the work. However, over the past few years, many publishers have substantially raised subscription prices for journals. This has coincided with a period of proliferation in the number of research papers published and the journals in which they are published, as researchers are encouraged to 'publish or perish'. Both these factors have created a situation commonly referred to as the 'serials crisis'; so-called because libraries can no longer afford to maintain the collections of journals to which they subscribe. The consequences of these financial constraints on the communication of scientific and medical information will ultimately lead to poorer health care as doctors are denied access to the most up-to-date medical information.
Access to research papers is also being hindered by the insistence of most publishers that authors give up the copyright of any research paper they want to publish. The upshot of this is that authors are unable to place their work on the Internet, preventing them from distributing their research findings. There is also criticism that journal publishing is slow and inefficient; manuscripts can often take over 6 months to be processed. In a fast-moving field of research, results can be out-of-date before they are even published.
Open access initiatives
These concerns have been addressed by a number of organisations and initiatives. In 1999, the National Institutes of Health in the US announced that it would provide a repository of full-text articles made freely available through the Internet. This service, known as PubMed Central <http://www. pubmedcentral.gov>, invited existing publishers to contribute by making original research papers available through the PubMed Central Web site. Unfortunately, few large publishers have contributed to PubMed Central, fearing that it will result in cancelled subscriptions and decreased profits. However, a few forwardthinking journals do provide their content, such as the British Medical Journal, the Journal of the Institute of Physics and BioMed Central's journals.
Following the reluctance of publishers to get involved in the PubMed Central initiative, the scientific community took matters into their own hands by forming an open access advocacy group known as The Public Library of Science (PLoS) <http://www. publiclibraryofscience.org>. Spearheaded by eminent life scientists, incensed by the failings of the larger traditional publishers, they created an open letter which has gathered around 30,000 signatories from 182 countries. The objective of the letter was to force the hand of publishers by insisting that a permanent, archival record of scientific research should belong to the public, and be freely available through an online public library. The signatories of this open letter pledged that 'beginning in September 2001, we will publish in, edit or review for, and personally subscribe to, only those scholarly and scientific journals that have agreed to grant unrestricted free distribution rights to any and all original research reports that they have published, through PubMed Central and similar online public resources, within 6 months of their initial publication date'.
When push came to shove, scientists were not willing to jeopardise their careers by boycotting high profile journals and the publishers were not willing to take up the challenge in fear that some institutions would cancel subscriptions. In a recent interview in 
Delivering open access
If open access is to be achieved, researchers must have peer-reviewed, open access journals in which to publish. BioMed Central was launched in May 2000 with a view to providing the tools to deliver barrier-free, full-text access to peer-reviewed research papers. Barrier-free access provides two clear advantages over conventional journals. Firstly, papers published in open access journals have high visibility. Each article published in the 80 or so BioMed Central journals receives an average of 200 downloads per month. Second, the publisher does not require the transfer of copyright from authors so they can keep control of their work and ensure that it is placed on a publicly accessible server.
Papers published in BioMed Central's journals are permanently and securely archived in PubMed Central as soon as they are published. They are also indexed in PubMed, BIOSIS and a number of other citation indexes, which makes them fully searchable. The innovative online submission, peer-review and publication processes have enabled the company to reduce the length of time from submission to publication to an average of 11 weeks.
BioMed Central is a commercial publisher and it funds open access through the payment of articleprocessing charges of US$500 per published article. However, waivers for this charge are available to authors from developing countries, and to those other authors who may not be able to pay. The company also runs an Institutional Membership Programme to take the pressure of paying the processing charge away from individual authors. Authors from institutions which become members of BioMed Central receive an automatic waiver of the processing charge each time they publish a paper with BioMed Central. The membership programme provides institutions with the means to give active support toopen access in scholarly publishing. 
Conclusions
Initiatives like HINARI show that large-scale cooperation between publishers is possible. However, most commercial publishers are not yet ready to consider alternative publishing models, as was demonstrated by their attitudes to the launch of PubMed Central and the open letter issued by the PLoS. Despite all the initiatives, little has changed in the last 5 years. Time will tell if open access publishing is set to replace subscription-based models. Whether there is a revolution will depend entirely on the authors of the research articles and the custodians of their work (the librarians and information professionals responsible for paying for it). They are not powerless. If every researcher decided to publish their next article in an open access journal, such as those published by BioMed Central, it would force the large commercial publishers to re-evaluate their business models. Librarians too have an important part to play in making their users aware of the open access alternatives.
